Life Science Shares Owned By Insiders vs. Market Capitalization
| LABS Stock | 39.00 0.20 0.52% |
For Life Science profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Life Science to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Life Science REIT utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Life Science's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Life Science REIT over time as well as its relative position and ranking within its peers.
Life |
Life Science REIT Market Capitalization vs. Shares Owned By Insiders Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Life Science's current stock value. Our valuation model uses many indicators to compare Life Science value to that of its competitors to determine the firm's financial worth. Life Science REIT is currently regarded as number one stock in shares owned by insiders category among its peers. It also is currently regarded as number one stock in market capitalization category among its peers creating about 19,097,173 of Market Capitalization per Shares Owned By Insiders. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Life Science's earnings, one of the primary drivers of an investment's value.Life Market Capitalization vs. Shares Owned By Insiders
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Life Science |
| = | 7.11 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Life Science |
| = | 135.8 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Life Market Capitalization vs Competition
Life Science REIT is currently regarded as number one stock in market capitalization category among its peers. Market capitalization of Real Estate industry is now estimated at about 1.53 Trillion. Life Science adds roughly 135.8 Million in market capitalization claiming only tiny portion of equities listed under Real Estate industry.
Life Science Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Life Science, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Life Science will eventually generate negative long term returns. The profitability progress is the general direction of Life Science's change in net profit over the period of time. It can combine multiple indicators of Life Science, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 321.8 M | 241.1 M | |
| Net Interest Income | -7.3 M | -6.9 M | |
| Interest Income | 3.8 M | 2.6 M | |
| Operating Income | 19.5 M | 20.5 M | |
| Net Loss | -21.7 M | -22.8 M | |
| Income Before Tax | -21.9 M | -22.9 M | |
| Total Other Income Expense Net | -41.4 M | -39.3 M | |
| Net Income Applicable To Common Shares | 16.7 M | 14.9 M | |
| Net Loss | -21.7 M | -22.8 M | |
| Income Tax Expense | -146 K | -138.7 K | |
| Change To Netincome | -17.6 M | -18.4 M |
Life Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Life Science. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Life Science position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Life Science's important profitability drivers and their relationship over time.
Use Life Science in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Life Science position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Life Science will appreciate offsetting losses from the drop in the long position's value.Life Science Pair Trading
Life Science REIT Pair Trading Analysis
The ability to find closely correlated positions to Life Science could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Life Science when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Life Science - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Life Science REIT to buy it.
The correlation of Life Science is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Life Science moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Life Science REIT moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Life Science can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Life Science position
In addition to having Life Science in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Services Thematic Idea Now
Services
Companies involved in delivering services to business or consumers across different industries and sectors. The Services theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Services Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Life Stock Analysis
When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.